[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582789":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":32,"responsibleParty":48,"collaborators":19,"id":50,"slug":19,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":58,"minAge":59,"maxAge":19,"enrollmentInfo":60,"targetDuration":19,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":19,"overallStatus":35,"whyStopped":19,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Women with diagnosis of PP and PAS","EXPERIMENTAL","Pregnant women with abnormal placentation as placenta previa and accreta spectrum",[13],"Procedure: Blood sample",[15],{"type":16,"name":17,"description":17,"armGroupLabels":18,"otherNames":19},"PROCEDURE","Blood sample",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Chiara Tersigni","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},"CONTACT","+39 3206557088","chiara.tersigni@policlinicogemelli.it",{"name":30,"role":26,"phone":19,"phoneExt":19,"email":31},"Marianna Onori","mariannaonori@gmail.com",[33],{"facility":34,"status":35,"city":36,"state":19,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Fondazione Policlinico Universitario A.Gemelli IRCSS","RECRUITING","Roma","00168","Italy","IT",{"type":41,"coordinates":42},"Point",[43,44],11.10642,44.99364,{"lat":44,"lon":43},[47],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},{"type":49,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100582789",false,"NCT06867874","Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum","Shedding of Syncytiotrophoblast-derived Extracellular Vesicles is Increased in Placenta Previa and Accreta Spectrum: a Case-control Study.","PAS","Inclusion Criteria:\n\n* Pregnant women with diagnosis of placenta previa and accreta spectrum (cases)\n* Healthy pregnant women\n* \\> 18 years\n\nExclusion Criteria:\n\n* \\\u003C 18 years\n* Twin pregnancies\n* Chronic Infections\n* Cancers\n* Unable to give the written consent",true,"FEMALE","18 Years",{"count":61,"type":62},70,"ESTIMATED","INTERVENTIONAL",[65],"NA","The main goal of this case-control study is to quantify the levels of circulating syncytiotrophoblast-derived extracellular vesicles (STBEVs) in maternal blood in a population of women with placenta previa and placenta accreta spectrum.",[68,69],"Placenta Previa","Placenta Accreta Spectrum","2025-03-05",{"date":72,"type":73},"2025-03-10","ACTUAL",{"date":75,"type":73},"2023-07-10",{"date":77,"type":62},"2026-03-01",{"name":5,"class":6},1]